4D Molecular Therapeutics Inc FDMT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:15 AM EDT
9.61quote price arrow up+0.07 (+0.73%)
Volume
9,194
52 week range
5.32 - 36.14
Loading...
  • Open9.34
  • Day High9.88
  • Day Low9.34
  • Prev Close9.54
  • 52 Week High36.14
  • 52 Week High Date09/23/21
  • 52 Week Low5.32
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap310.40M
  • Shares Out32.30M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-56.65

KEY STATS

  • Open9.34
  • Day High9.88
  • Day Low9.34
  • Prev Close9.54
  • 52 Week High36.14
  • 52 Week High Date09/23/21
  • 52 Week Low5.32
  • 52 Week Low Date06/16/22
  • Market Cap310.40M
  • Shares Out32.30M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-56.65

RATIOS/PROFITABILITY

  • EPS (TTM)-3.33
  • P/E (TTM)-2.88
  • Fwd P/E (NTM)-3.71
  • EBITDA (TTM)-100.589M
  • ROE (TTM)-39.65%
  • Revenue (TTM)2.84M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-3,583.87%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On 4D Molecular Therapeutics Inc

There is no recent news for this security.

Profile

MORE
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company. The Company is focused on creating and developing targeted and evolved adeno-associated viruses (AAV) vectors. The Company’s product candidates are focused various areas, including ophthalmology, cardiology, and pulmonology. The Company's product candidates include 4D-125, 4D-150, 4D-110, 4D-310, and 4D-710. 4D-125 for the treatment of patients with X-Linked Retinitis Pigmentosa (XLRP) with retinitis...
John Milligan Ph.D.
Executive Chairman of the Board
David Kirn M.D.
Chief Executive Officer, Co-Founder, Director
August Moretti J.D.
Chief Financial Officer
Address
5858 Horton Street #455, Emeryville
Emeryville, CA
94608
United States

Top Peers

SYMBOLLASTCHG%CHG
CMPX
Compass Therapeutics Inc.
3.00UNCHUNCH
KRON
Kronos Bio Inc
5.30-0.08-1.49%
OMIC
Singular Genomics Systems Inc
4.29+0.11+2.63%
AADI
Aadi Bioscience Inc
13.86-0.09-0.65%
VKTX
Viking Therapeutics Inc
3.76UNCHUNCH